Literature DB >> 12948858

Generation of oxidant stress in cultured endothelial cells by methylene blue: protective effects of glucose and ascorbic acid.

James M May1, Zhi-chao Qu, Richard R Whitesell.   

Abstract

The thiazine dye methylene blue has long been used to stimulate cellular redox metabolism. To determine the extent to which it also generates oxidant stress in cells, its effects in cultured human-derived endothelial cells were studied. As expected, low concentrations of the dye (2-20 microM) activated the pentose phosphate pathway and oxidized both NADPH and NADH. Methylene blue enhanced extracellular ferricyanide reduction, indicating that the reduced form of the dye was present outside the cells. This reduction was greater when ferricyanide was added just before rather than 15 min after methylene blue, confirming that the dye is at least initially reduced at the cell surface. In the absence of glucose, methylene blue at concentrations above 5 microM increased intracellular oxidant stress, as manifest by oxidation of dihydrofluorescein and cellular GSH. Inclusion of glucose protected against these effects. In cells that had been loaded with ascorbate, the dye caused progressive oxidation of ascorbate, even in the presence of D-glucose. Loading cells with ascorbate also partially prevented oxidation of dihydrofluorescein by methylene blue. These results suggest that concentrations of the dye above 5 microM generated intracellular reactive oxygen species that were scavenged by ascorbate and GSH. Further, although D-glucose enhanced reduction of methylene blue, it ameliorated the oxidant stress generated by the dye.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948858     DOI: 10.1016/s0006-2952(03)00408-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Assessing the reductive capacity of cells by measuring the recycling of ascorbic and lipoic acids.

Authors:  James M May
Journal:  Methods Mol Biol       Date:  2010

Review 2.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

3.  Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.

Authors:  R R Ramsay; C Dunford; P K Gillman
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

4.  Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.

Authors:  Andrew R Schneider; Youssef Sari
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

5.  Minimal detection of nuclear mutations in XP-V and normal cells treated with oxidative stress inducing agents.

Authors:  Kimberly N Herman; Shannon Toffton; Scott D McCulloch
Journal:  J Biochem Mol Toxicol       Date:  2014-08-28       Impact factor: 3.642

6.  P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy.

Authors:  Paulo Anastácio Furtado Pacheco; Leonardo Braga Gomes Ferreira; Leonardo Mendonça; Dinarte Neto M Ferreira; Juliana Pimenta Salles; Robson Xavier Faria; Pedro Celso Nogueira Teixeira; Luiz Anastacio Alves
Journal:  J Bioenerg Biomembr       Date:  2016-07-15       Impact factor: 2.945

7.  Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in vivo Study.

Authors:  Juhyun Song; Joohyun Park; Jae Hwan Kim; Ja Yong Choi; Jae Young Kim; Kyoung Min Lee; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2015-01-29       Impact factor: 3.261

8.  Nonphotodynamic Roles of Methylene Blue: Display of Distinct Antimycobacterial and Anticandidal Mode of Actions.

Authors:  Rahul Pal; Moiz A Ansari; Venkata Saibabu; Shrayanee Das; Zeeshan Fatima; Saif Hameed
Journal:  J Pathog       Date:  2018-01-31

9.  Rapid and Selective Targeting of Heterogeneous Pancreatic Neuroendocrine Tumors.

Authors:  G Kate Park; Jeong Heon Lee; Eduardo Soriano; Myunghwan Choi; Kai Bao; Wataru Katagiri; Do-Yeon Kim; Ji-Hye Paik; Seok-Hyun Yun; John V Frangioni; Thomas E Clancy; Satoshi Kashiwagi; Maged Henary; Hak Soo Choi
Journal:  iScience       Date:  2020-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.